|Day Low/High||138.78 / 142.00|
|52 Wk Low/High||105.64 / 147.42|
When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.
TheStreet’s Jim Cramer said bank stocks hit bottom last month, and talk of negative interest rates are not a worry for U.S. bank stocks.
Two significant, but subtle forces may threaten the group in the next 12 months.
Peter Boockvar touches on central bankers and the weak earnings picture in this morning's commentary: "While IBM (IBM) has its issues, the response to its earnings is a reminder that at least so far this earnings season, your stock is fine as long a...
ETFs and futures can distort even the most straightforward of markets.
Have we reached the point where something will be done about it?
If you believe that the U.S. avoids recession, credit is interesting here.
If you agree that domestic growth is strong and implied volatility is excessive in some names, this may be a good time to consider selling puts the stocks of companies with a U.S. focus and positive year-over-year revenue growth.
Jim Cramer answers viewers' Twitter questions on investing in Alcoa (AA), HCA Holdings (HCA), Citigroup (C), American Airlines (AAL) Monday from the floor of the NYSE.
The energy and materials sectors dragged the averages lower.
Grexit woes continue to depress prices, but SCOTUS helps hospitals.
It was a rough day on Wall Street Thursday, as all three major indices closed lower, after posting gains earlier in the trading session.
By a 6-3 vote, the U.S. Supreme Court's ruling on Obamacare handed President Obama a victory, and gave investors an opportunity in the healthcare space.
Today's ruling removes a significant overhang from the sector and stock prices.
Regional hospital operators like Tenet Healthcare (THC), HCA Holdings (HCA) and Community Health Systems (CYH) won’t see long-term headwinds if the Supreme Court rules against Obamacare.